45 Results for "

cognitive-enhancing

" in MedChemExpress (MCE) Product Catalog:
Products (45)

45 Results for "cognitive-enhancing" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-17387
CAS No.: 102518-79-6
Synonyms: Huperzine A
(-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-105896
CAS No.: 402713-80-8
Purity:  98.85%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SB399885 is a potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist with pKi values 9.11 and 9.02 for human recombinant and native 5-HT6 receptors, respectively. SB399885 has cognitive enhancing properties .
loading...
    loading...
Cat. No.: HY-11013
CAS No.: 887603-94-3
Purity:  98.01%
Synonyms: ST-101
Target:  

Calcium Channel nAChR

Research Areas:  

Neurological Disease Cancer

ZSET1446 is a novel cognitive enhancer that significantly improves learning deficits in various types of Alzheimer disease (AD) models.
loading...
    loading...
Cat. No.: HY-17550
CAS No.: 314728-85-3
Synonyms: DM-235
Target:  

iGluR

Research Areas:  

Neurological Disease

Sunifiram (DM-235) is an ampakine-like compound and an agonist of AMPA receptor with oral activity. Sunifiram can increase the release of acetylcholine in the rat cerebral cortex and exhibits potent cognitive enhancement effects with better nootropic activity compared to piracetam (HY-B0585). Sunifiram is promising for research in neurodegenerative diseases such as mild cognitive impairment (MCI) and Alzheimer's disease (AD) .
loading...
    loading...
Cat. No.: HY-13779
CAS No.: 1146963-51-0
Purity:  99.80%
(E/Z)-J147 is an exceptionally potent, orally active, neuroprotective agent for cognitive enhancement. (E/Z)-J147 can readily pass the blood brain barrier (BBB). (E/Z)-J147 can inhibit monoamine oxidase B (MAO B) and the dopamine transporter with EC50 values of 1.88 μM and 0.649 μM, respectively. (E/Z)-J147 has potential for the study of Alzheimer’s disease (AD) .
loading...
    loading...
Cat. No.: HY-N1414
CAS No.: 139891-98-8
(E)-3',6-Disinapoylsucrose is an orally active, blood-brain barrier permeable neuroprotective agent that inhibits protein aggregation. (E)-3',6-Disinapoylsucrose exerts anxiolytic, anti-inflammatory and cognitive-enhancing effects. (E)-3',6-Disinapoylsucrose regulates the TrkB/BDNF signaling pathway, inhibits the expression of NF-κB p65, reduces pro-inflammatory cytokine levels, and alleviates neuronal damage. (E)-3',6-Disinapoylsucrose also enhances the functions of central 5-HT and noradrenergic systems, thereby improving spatial learning and memory abilities and reducing anxiety-like behaviors. (E)-3',6-Disinapoylsucrose can be used for the research of related diseases such as Alzheimer's disease, depression, memory impairment and anxiety disorder .
loading...
    loading...
Cat. No.: HY-125931
CAS No.: 272786-64-8
Purity:  99.78%
Synonyms: DM232
Target:  

iGluR

Unifiram (DM232) is a AMPA receptor activator and cognitive enhancer. Unifiram activates the AMPA-mediated neurotransmission system. Unifiram reverses NBQX-induced amnesia in the passive avoidance test in mice. Unifiram reverses the antagonistic effect of kynurenic acid on NMDA-mediated [ 3H]NA release in rat hippocampal slices. Unifiram enhances excitatory synaptic transmission in the rat hippocampus in vitro. Unifiram can be used in studies related to amnesia and cognitive dysfunction, including age-related memory decline, neurodegenerative diseases such as Alzheimer's disease or Parkinson's disease, multiple sclerosis, schizophrenia, and attention deficit hyperactivity disorder .
loading...
    loading...
Cat. No.: HY-116800
CAS No.: 202646-80-8
Purity:  98.1%
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease

FR194921 is a potent, selective and orally active and cross the blood-brain barrier Adenosine A1 antagonist with Ki value of 6.6, 5400 nM for A1, A2A, respectively. FR194921 shows cognitive-enhancing and anxiolytic activity .
loading...
    loading...
Cat. No.: HY-10936
CAS No.: 175340-20-2
Purity:  99.85%
Target:  

iGluR

Research Areas:  

Neurological Disease

S 18986 is a selective, orally active, brain penetrant positive allosteric modulator of AMPA-type receptors. S 18986 shows cognitive enhancing properties in rodents. S 18986 activates the release of noradrenaline and acetylcholine in rat hippocampus and enhances rat memory in object-recognition tests .
loading...
    loading...
Cat. No.: HY-13779A
CAS No.: 1807913-16-1
Purity:  99.90%
J147 is an exceptionally potent, orally active, neuroprotective agent for cognitive enhancement. J147 can pass the blood brain barrier (BBB). J147 can inhibit monoamine oxidase B (MAO B) and the dopamine transporter. J147 plays an impotant role in Alzheimer’s disease (AD) .
loading...
    loading...
Cat. No.: HY-W049881
CAS No.: 2521-07-5
9-Methyl-β-carboline is a monoamine oxidase inhibitor and dopaminergic modulator, with an IC50 of 1 μM against human MAO-A and an IC50 of 15.5 μM against human MAO-B. 9-Methyl-β-carboline possesses cognitive enhancement potential and can cross the blood-brain barrier. 9-Methyl-β-carboline increases dopamine levels by inhibiting monoamine oxidase activity and microglial proliferation. 9-Methyl-β-carboline activates PKA/PKC and mitochondrial respiratory chain complex I, promotes neurotrophic factor expression and reduces α-synuclein (α-synuclein) levels, thereby reversing neurotoxin-induced dopaminergic neuron damage. 9-Methyl-β-carboline also regulates the PI3K pathway and exerts an anti-proliferative effect on astrocytes. 9-Methyl-β-carboline is widely used in Parkinson's disease-related studies .
loading...
    loading...
Cat. No.: HY-133025
CAS No.: 283167-06-6
Purity:  99.89%
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

FK962 is an enhancer of somatostatin release, exerts cognitive-enhancing actions. Anti-dementia properties .
loading...
    loading...
Cat. No.: HY-105022
CAS No.: 104383-17-7
Purity:  99.82%
Synonyms: R 58735
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Sabeluzole (R 58735), a benzothiazol derivative, has antiischemic, antiepileptic, and cognitive-enhancing properties. Sabeluzole protects rat hippocampal neurons against NMDA- and glutamate-induced neurotoxicity via preventing tau expression. Sabeluzole enhances memory in rats, and prevents the amnesic effect of Chlordiazepoxide. Sabeluzole can be used fro research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-160239
CAS No.: 1110650-74-2
Target:  

Aminopeptidase

Research Areas:  

Neurological Disease

HFI-437 is a potent non-peptidic insulin-regulated aminopeptidase (IRAP) inhibitor with a Ki of 20 nM. HFI-437 is a cognitive enhancer .
loading...
    loading...
Cat. No.: HY-19742A
CAS No.: 433282-68-9
Synonyms: SRA-333 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Lecozotan (SRA-333) hydrochloride is an orally active and selective antagonist of 5-HT1A with a Ki of 4.5 nM for cloned human 5-HT1A receptor. Lecozotan hydrochloride enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. Lecozotan hydrochloride has the potential for mild-to-moderate Alzheimer's disease (AD) research .
loading...
    loading...
Cat. No.: HY-105170B
CAS No.: 147388-83-8
Purity:  99.37%
Target:  

nAChR

Research Areas:  

Neurological Disease

ABT-418 hydrochloride is a potent and selective agonist of nAChRs with cognitive enhancing and anxiolytic activities. ABT-418 hydrochloride activates cholinergic channel and can be used for research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-107676
CAS No.: 191611-89-9
Purity:  99.09%
Target:  

nAChR

Research Areas:  

Neurological Disease

SIB-1553A is an orally bioavailable nicotinic acetylcholine receptors (nAChRs) agonist, with selectivity for β4 subunit-containing nAChRs. SIB-1553A is also a selective neuronal nAChR ligand. SIB-1553A is a cognitive enhancer, and has therapeutic potential for the symptomatic treatment of Alzheimer’s disease and other cognitive disorders .
loading...
    loading...
Cat. No.: HY-105022R
CAS No.: 104383-17-7
Synonyms: R 58735 (Standard)
Research Areas:  

Neurological Disease

Sabeluzole (Standard) is the analytical standard of Sabeluzole. This product is intended for research and analytical applications. Sabeluzole (R 58735), a benzothiazol derivative, has antiischemic, antiepileptic, and cognitive-enhancing properties. Sabeluzole protects rat hippocampal neurons against NMDA- and glutamate-induced neurotoxicity via preventing tau expression. Sabeluzole enhances memory in rats, and prevents the amnesic effect of Chlordiazepoxide. Sabeluzole can be used fro research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-U00114
CAS No.: 324077-62-5
Target:  

Acyltransferase

Research Areas:  

Neurological Disease

ZSET-845 is a cognitive enhancer which enhances choline acetyltransferase activity in the hippocampus in the rat.
loading...
    loading...
Cat. No.: HY-106933A
CAS No.: 153049-48-0
Synonyms: S 12024-2
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

Dabelotine (methanesulfonate) is a cognitive enhancer. Dabelotine (methanesulfonate) can be used for Alzheimer disease (AD) research .
loading...
    loading...